Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial

Piliang, M., Lynde, C., King, B., Mirmirani, P., Sinclair, R., Senna, M., Forman, S., Bordone, L., De La Cueva Dobao, P., Wolk, R., Zwillich, S. H., Tran, H., Wajsbrot, D., Ahmed, H. M., & Takiya, L. (2024). Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2024.09.064

Authors:

Melissa Piliang

Charles Lynde

Brett King

Paradi Mirmirani

Rodney Sinclair

Maryanne Senna

Seth Forman

Lindsey Bordone

Pablo De La Cueva Dobao

Robert Wolk

Samuel H Zwillich